FDA approves Telix brain cancer imaging drug Pixclara for glioma PET scans
Reuters2026/09/13 22:32- FDA cleared Telix’s Pixclara, an F-18 PET imaging drug for glioma, marking the first approved FET-PET agent in the US.
- Label covers adults, pediatric patients from 1 month old, to help distinguish recurrent or progressive glioma from treatment-related changes.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas
A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.
Franco-Nevada buys A$170 million Bullabulling gold project royalty from Minerals 260
10-Yr Benchmark Govt Yields - Germany vs Other Nations
Crypto prices
More
